Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases

Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis

(2014) Parawee Suwannalai et al.   Modern Rheumatology

PADI4 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis

(2014) Sai Hou et al.   Modern Rheumatology

Two novel sandwich ELISAs identify PAD4 levels and PAD4 autoantibodies in patients with rheumatoid arthritis

(2014) Akihito Ishigami et al.   Modern Rheumatology

Prevalence of Anti-Peptidylarginine Deiminase Type 4 Antibodies in Rheumatoid Arthritis and Unaffected First-degree Relatives in Indigenous North American Populations

(2013) E. D. Ferucci et al.   JOURNAL OF RHEUMATOLOGY

Erosive Rheumatoid Arthritis Is Associated with Antibodies That Activate PAD4 by Increasing Calcium Sensitivity

(2013) E. Darrah et al.   Science Translational Medicine

Anti-citrullinated glucose-6-phosphate isomerase peptide antibodies in patients with rheumatoid arthritis are associated withHLA-DRB1shared epitope alleles and disease activity

(2012) N. Umeda et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

(2010) D. Aletaha et al.   ANNALS OF THE RHEUMATIC DISEASES

Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis

(2010) Jason R. Kolfenbach et al.   ARTHRITIS AND RHEUMATISM

Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation

(2010) Felipe Andrade et al.   ARTHRITIS AND RHEUMATISM

Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis

(2009) Natalia Wegner et al.   IMMUNOLOGICAL REVIEWS

Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles

(2008) O Snir et al.   ANNALS OF THE RHEUMATIC DISEASES

Antibodies to citrullinated α-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase

(2008) Karin Lundberg et al.   ARTHRITIS AND RHEUMATISM